| 摘要 |
(57) The present invention relates to the use of leukaemia inhibitory factor (LiF), alone or in combination witj other cytokines such as interleukin-6 (IL-6) and/or transforming growth factor .alpha.(FGF.alpha.) and/or fibroblast growth factor (FGF), to stimulate the ?liferation and/or differentiation of mammalian satellite cells. THe present invention also contemplates a method comprising ?yoblast transfer therapy whereby LIF, alone or in combination with other cytokines, is/are employed to proliferate and/or differentiate mammalian satellite cells into myoblasts. The present invention is also directed to a cell activating composition and a pharmaceutical composition comprising LIF alone or in combination with other cytokines to promote proliferation and/or differentiation of mammalian satellite cells in vitro and in vivo, respectively.
|
